Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Cardlytics Stock Soared 43% on Wednesday

By Steve Symington - Nov 14, 2019 at 7:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors cheered a strong beat-and-raise performance from the purchase-intelligence platform leader.

What happened

Shares of Cardlytics ( CDLX -3.51% ) skyrocketed 42.9% on Wednesday after the purchase-intelligence technology company posted a surprise non-GAAP (adjusted) profit in the third quarter and raised its full-year outlook.

So what

More specifically on the former, Cardlytics' quarterly revenue grew 63% year over year to $56.4 million, translating to adjusted net income of $800,000, or $0.03 per share. By comparison, Cardlytics' guidance provided in August called for lower revenue of $46 million to $50 million, and most analysts were modeling an adjusted loss of $0.15 per share.

Man in white shirt and tie celebrating in front of wooden chart indicating gains.


Cardlytics' billings also soared 70% year over year to $82.8 million, well above its guidance for a range of $70 million to $76 million.

"With our successful rollout of Chase complete and our upcoming rollout of Wells Fargo, our scale gives marketers the ability to reach bank customers at massive scale," added Cardlytics Co-Founder and COO Lynne Laube. "Our ongoing initiatives to penetrate new verticals and enable a more automated buying model positions Cardlytics extraordinarily well for continued growth."

Now what

For the fourth quarter, Cardlytics sees revenue arriving in the range of $55 million to $59 million, with billings of $82 million to $88 million.

As such, Cardlytics raised its full-year guidance to call for 2019 revenue of $196 million to $200 million (up from $180 million to $190 million before), and billings of $297 million to $303 million (up from $275 million to $290 million previously).

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cardlytics Stock Quote
$65.21 (-3.51%) $-2.37

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.